Pherecydes Pharma

Pherecydes Pharma

A biotechnology company developing phage therapies for treating bacterial infections.

All edits

Edits on 13 Aug, 2020
Lax Mariappan
Lax Mariappan edited on 13 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Founded date
2006
Edits on 4 Aug, 2020
Marie Gabrielle Laguna- Bedia
Marie Gabrielle Laguna- Bedia edited on 4 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
CEO
Guy-Charles Fanneau de La Horie
Edits on 1 Aug, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 1 Aug, 2020
Edits made to:
Infobox (+1/-1 properties)
Infobox
Total funding amount (USD)
15,555,000
Total funding amount (USD)
16,707,000
Golden AI
Golden AI edited on 1 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Pherecydes Pharma Grant January 2012
Golden AI"Funding autocalculation"
Golden AI edited on 1 Aug, 2020
Edits made to:
Infobox (+1/-1 properties)
Infobox
Total funding amount (USD)
12,780,000
Total funding amount (USD)
15,555,000
Golden AI
Golden AI edited on 1 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Pherecydes Pharma Venture Funding Round March 2015
Golden AI"Funding autocalculation"
Golden AI edited on 1 Aug, 2020
Edits made to:
Infobox (+1/-1 properties)
Infobox
Total funding amount (USD)
2,520,000
Total funding amount (USD)
12,780,000
Golden AI
Golden AI edited on 1 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Pherecydes Pharma Series B Funding Round January 2018
Golden AI"Funding autocalculation"
Golden AI edited on 1 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Total funding amount (USD)
2,520,000
Golden AI
Golden AI edited on 1 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Pherecydes Pharma Series A Funding Round December 2014
Edits on 31 Jul, 2020
Aime Anne Nisay
Aime Anne Nisay edited on 31 Jul, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 30 Jul, 2020
Lax Mariappan
Lax Mariappan edited on 30 Jul, 2020
Edits made to:
Infobox (+2 properties)
Infobox
Founder
Jerome Gabard
Edits on 28 Feb, 2020
Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 28 Feb, 2020
Edits made to:
Article (+14/-14 characters)
Article

On January 16, 2018 Pherecydes Pharma completed their series A funding round with €8.7 million in funding from Go Capital (lead investor), Omnes Capital, FaDiese, Auriga Partners, and ACE ManagementACE Management.

Edits on 20 Jan, 2020
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 20 Jan, 2020
Edits made to:
Article (+10/-10 characters)
Article

On January 16, 2018 Pherecydes Pharma completed their series A funding round with €8.7 million in funding from Go CapitalGo Capital (lead investor), Omnes Capital, FaDiese, Auriga Partners, and ACE Management.

Golden AI
Golden AI edited on 20 Jan, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Investors
ACE Management
Edits on 19 Nov, 2019
Golden AI
Golden AI edited on 19 Nov, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Investors
Auriga Partners
Edits on 2 May, 2019
Henry Ogolla"Approved suggestion from source: https://www.pherecydes-pharma.com/"
Henry Ogolla approved a suggestion from Golden's AI on 2 May, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 11 Apr, 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 11 Apr, 2019
Edits made to:
Article (+13/-13 characters)
Article

On January 16, 2018 Pherecydes Pharma completed their series A funding round with €8.7 million in funding from Go Capital (lead investor), Omnes CapitalOmnes Capital, FaDiese, Auriga Partners, and ACE Management.

Edits on 4 Apr, 2019
Dawson Sewell
Dawson Sewell edited on 4 Apr, 2019
Edits made to:
Infobox (+10 properties)
Description (+86 characters)
Article (+563 characters)
Further reading (+1 rows) (+4 cells) (+185 characters)
Categories (+1 topics)
Related Topics (+1 topics)
Topic thumbnail

Pherecydes Pharma

A biotechnology company developing phage therapies for treating bacterial infections.

Article

Pherecydes Pharma is a biotechnology company developing phage therapies for fighting bacterial infections that is headquartered in Romainville, France and was founded in 2006 by Jerome Gabard and Manuel Gea.

Funding

Series A

On December 1, 2014 Pherecydes Pharma completed their series A funding round with €1.9 million in funding from Auriga Partners.

Series B

On January 16, 2018 Pherecydes Pharma completed their series A funding round with €8.7 million in funding from Go Capital (lead investor), Omnes Capital, FaDiese, Auriga Partners, and ACE Management.

Further reading

Title
Author
Link
Type

Biotech raises funds to help produce phage therapies for bacterial infections

epmmagazine

Web

Infobox
Is a
Company
Industry
Biotechnology
Location
Romainville
Date incorporated
2006
Categories
Related Topics
Edits on 21 Jan, 2019
Meredith Hanel"Initial topic creation"
Meredith Hanel created this topic on 21 Jan, 2019
Edits made to:
Topic thumbnail

 Pherecydes Pharma

A biotechnology company developing phage therapies for treating bacterial infections.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.